7-((5-(2-Bromophenyl)-1,3,4-oxadiazol-2-yl)methoxy)-2H-chromen-2-one

Catalog No. :
ACHBAT803
CAS No. :
784169-89-7
Molecular Formula :
C18H11BrN2O4
Molecular Weight :
399.20

IUPAC Name:7-((5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl)methoxy)-2H-chromen-2-one

7-((5-(2-Bromophenyl)-1,3,4-oxadiazol-2-yl)methoxy)-2H-chromen-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg98%$90.00Login to see priceInquiryInquiry
25mg98%$138.00Login to see priceInquiryInquiry
100mg98%$318.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-((5-(2-Bromophenyl)-1,3,4-oxadiazol-2-yl)methoxy)-2H-chromen-2-one
IUPAC Name7-((5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl)methoxy)-2H-chromen-2-one
Molecular FormulaC18H11BrN2O4
Molecular Weight399.20
SMILESO=C1C=CC2=CC=C(OCC3=NN=C(C4=CC=CC=C4Br)O3)C=C2O1
InChI KeyXKTDCSNRKCIWRV-UHFFFAOYSA-N
Synonym2H-1-Benzopyran-2-one, 7-[[5-(2-bromophenyl)-1,3,4-oxadiazol-2-yl]methoxy]-;7-((5-(2-Bromophenyl)-1,3,4-oxadiazol-2-yl)methoxy)-2H-chromen-2-one;WAY-632889
CAS No.784169-89-7
PubChem CID2114786

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACHBAT803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHFOR035 route compound structure diagram
    ACHFOR03593-35-6 In Stock
  4. Then
  5. ACHBAT803 route product structure diagram
    ACHBAT803784169-89-7 In Stock
Inquiry

2. ACHBAT803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHBAT803 route product structure diagram
    ACHBAT803784169-89-7 In Stock
Inquiry

Comments (0)